SCHEMBL765461

SCHEMBL765461

CCOC(=O)c1ccoc1Cc1ccc(F)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.51
ALDH1A1 P00352 3/20 0.51
HSD17B10 Q99714 2/20 0.51
POLB P06746 1/20 0.49
HTT P42858 1/20 0.49
KDM4E B2RXH2 3/20 0.48
LMNA P02545 3/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
HPGD P15428 2/20 0.48
NPSR1 Q6W5P4 2/20 0.48
ALOX12 P18054 1/20 0.48
CCR6 P51684 1/20 0.48
HKDC1 Q2TB90 1/20 0.48
KDM4C Q9H3R0 1/20 0.48
RAB9A P51151 2/20 0.47
PDE3B Q13370 1/20 0.46
PDE3A Q14432 1/20 0.46
TSHR P16473 2/20 0.42
CASP3 P42574 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11400583 0.86 TSHR (0.53) MAPTALDH1A1HSD17B10KDM4ENPSR1
SCHEMBL758569 0.81 MAOB (0.41) ALDH1A1HSD17B10POLBLMNAKMT2A
SCHEMBL752322 0.79 TP53 (0.47) HSD17B10POLBLMNAKMT2ACASP3
SCHEMBL8635719 0.79 ALDH1A1 (0.53) MAPTALDH1A1HSD17B10KDM4EMEN1
SCHEMBL765016 0.78 POLB (0.43) MAPTALDH1A1HSD17B10POLBKDM4E
SCHEMBL755300 0.77 PDE3B (0.46) MAPTALDH1A1HSD17B10POLBHTT
SCHEMBL6977127 0.76 ALDH1A1 (0.51) MAPTALDH1A1HSD17B10KDM4EMEN1
SCHEMBL1436063 0.76 ALDH1A1 (0.51) MAPTALDH1A1HSD17B10KDM4EMEN1
SCHEMBL12206952 0.76 RAB9A (0.38) MAPTALDH1A1HSD17B10POLBHTT
SCHEMBL823438 0.76 ALDH1A1 (0.46) MAPTALDH1A1POLBHTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170066754-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2017-03-09 US disclosed
US-20170066754-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2017-03-09 US disclosed
US-20170066754-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2017-03-09 US disclosed
US-9572813-B2 Antiviral agent SHIONOGI & CO., LTD. (JP) 2017-02-21 US disclosed
US-9572813-B2 Antiviral agent SHIONOGI & CO., LTD. (JP) 2017-02-21 US disclosed
US-9572813-B2 Antiviral agent SHIONOGI & CO., LTD. (JP) 2017-02-21 US disclosed
US-20150202208-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2015-07-23 US disclosed
US-20150202208-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2015-07-23 US disclosed
US-20150202208-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2015-07-23 US disclosed
EP-1422218-B1 ANTIVIRAL AGENT SHIONOGI & CO (JP) 2012-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150202208-A1 ANTIVIRAL AGENT ZC3HAV1, ZC3HAV1L, CCNI MAPT 4426/4885ALDH1A1 424/4885HSD17B10 1765/4885
US-20170066754-A1 ANTIVIRAL AGENT ZC3HAV1, ZC3HAV1L, CCNI MAPT 4426/4885ALDH1A1 424/4885HSD17B10 1765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.